Imugene Market Cap

Imugene has a market cap or net worth of 282.62 million as of December 3, 2024. Its market cap has decreased by -53.04% in one year.

Market Cap

282.62M

Enterprise Value

190.79M

Revenue

4.97M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.04

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 282.62M, an increase of 3,730.12%. That is a compound annual growth rate of 17.82%.

Market Cap History

Date	Market Cap	% Change
Dec 3, 2024	282.62M	-64.16%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	141.63M	117.97%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	136.65B
ResMed Inc.	56.11B
Pro Medicus Limited	26.32B
Fisher & Paykel Healthcare Corporation Limited	20.25B
Cochlear Limited	19.91B
Sonic Healthcare Limited	13.72B
Ramsay Health Care Limited	9.08B
Telix Pharmaceuticals Limited	8.28B

Market Cap Rankings